National Comprehensive Cancer Network



About NCCN

Colon/Rectal/Anal Cancers Panel - Disclosures as of 6/29/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

J. Pablo Arnoletti, MD

None

None

None

None

5/3/2011

Al B. Benson III, MD, FACP

None

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Enzon Pharmaceuticals;
Genentech, Inc.;
General Electric;
Genomic Health, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

8/31/2012

Emily Chan, MD, PhD

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genentech, Inc.

None

None

11/5/2012

Yi-Jen Chen, MD, PhD

None

None

None

None

5/16/2013

Michael A. Choti, MD, MBA

None

Genentech, Inc.;
sanofi-aventis U.S.

None

None

2/12/2013

Harry S. Cooper, MD

None

None

None

None

11/25/2012

Raza A. Dilawari, MD

None

Eisai Inc.;
Pfizer Inc.;
Schering-Plough Corporation

None

None

6/6/2011

Paul F. Engstrom, MD, FACP

None

Novartis Pharmaceuticals Corporation

None

None

2/27/2013

Peter C. Enzinger, MD

None

Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

4/4/2013

James W. Fleshman, Jr., MD

None

None

None

None

6/1/2011

Charles S. Fuchs, MD, MPH

Amgen Inc.;
ImClone Systems Incorporated

AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
ImClone Systems Incorporated;
Merck & Co., Inc.;
Myriad Genetic Laboratories, Inc.;
Alnylam;
Roche Laboratories, Inc.

None

None

6/14/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Jean L. Grem, MD

None

Adherex Technologies Inc.

None

None

8/16/2012

James A. Knol, MD

None

None

None

None

4/25/2011

Lucille A. Leong, MD

None

None

None

None

6/11/2012

Edward Lin, MD

None

None

None

None

10/12/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Susan Moench, PhD

None

None

None

None

7/29/2010

Mary F. Mulcahy, MD

None

None

None

None

1/26/2012

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

David P. Ryan, MD

None

Genentech, Inc.;
sanofi-aventis U.S.

None

None

11/3/2011

Leonard Saltz, MD

None

Abbott Laboratories;
Celgene Corporation;
Exelixis Inc.;
Genentech, Inc.;
ImClone Systems Incorporated

None

None

8/27/2012

Sunil Sharma, MD

None

None

None

None

6/21/2011

David Shibata, MD

None

None

None

None

6/7/2012

John M. Skibber, MD

None

None

None

None

10/25/2012

William Small, MD

None

DOR BioPharma, Inc.

None

None

6/5/2012

Constantinos T. Sofocleous, MD, PhD, FSIR

National Cancer Institute;
Sirtex

None

None

None

6/5/2012

James P. Thomas, MD, PhD

None

None

None

None

7/6/2009

Alan P. Venook, MD

None

None

None

None

4/30/2012

Christopher G. Willett, MD

None

None

None

None

11/14/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved